America’s Vaccine Skepticism Is Starting to Show up in Health Data

Why It Matters

The erosion of universal newborn hepatitis B vaccination threatens a resurgence of infant infections and illustrates how politicized health policy can undermine long‑standing public‑health safeguards.

Key Takeaways

• Hepatitis B birth dose fell from 83.5% to 73.2%.
• CDC moved six vaccines to shared decision‑making.
• Study estimates 400,000 infants decline vaccine annually.
• State policies now diverge, reflecting partisan splits.

Pulse Analysis

The hepatitis B birth‑dose has been a cornerstone of U.S. infant health since its universal adoption in 1991, slashing perinatal infections from dozens to fewer than twenty annually. The new JAMA study, which examined 12.4 million births across Epic‑using hospitals, quantifies a sharp reversal: a ten‑point drop in coverage within two years. This decline is not merely a statistical blip; it reflects a broader shift in parental attitudes shaped by the COVID‑19 vaccine controversy and growing distrust of federal health agencies.

In January, the CDC reclassified hepatitis B and five other childhood vaccines from mandatory recommendations to "shared clinical decision‑making," effectively handing the choice to parents and physicians. The move aligns with a political narrative championed by figures such as Robert F. Kennedy Jr., who frame the vaccine as an unnecessary intervention for a sexually transmitted disease. By removing a universal mandate, the agency has inadvertently legitimized the hesitancy already evident in the data, creating a feedback loop where policy and public sentiment reinforce each other.

The public‑health fallout could be substantial. Modeling suggests hundreds of additional infant hepatitis B infections each year, with ripple effects on herd immunity and future disease burden. State responses are already polarized: Democratic‑led states largely retain the universal schedule, while many Republican‑led states adopt the CDC’s new guidance. This patchwork approach risks turning vaccine coverage into a partisan issue rather than a science‑driven standard, underscoring the need for coordinated federal leadership and robust health‑system infrastructure to protect vulnerable newborns.